Illumina’s Alliance for Genomic Discovery added Alnylam as a partner, expanding pharma access to a large, clinically annotated genomic dataset sequenced from Vanderbilt’s BioVU biobank, per reporting at industry meetings. Illumina and partner companies are pitching aggregated genomic resources to aid target discovery and translational research. Separately, the Long Life Family Study selected PacBio’s HiFi long‑read sequencing to profile up to 7,800 participants, a move to capture structural variants and methylation patterns missed by short reads. Together these announcements reflect growing industry investment in comprehensive, longitudinal sequencing to power target validation, biomarker discovery, and aging biology programs.